About Us
Advanced Medical Material Corp.
Since its establishment in 2017, Advanced Medical Material Corp. has been dedicated to bringing high-quality, competitively priced medical devices to Taiwan, offering patients more diverse and reliable treatment options.
Background
Company Background
Advanced Medical Material Corp. (AMM) was established in Taiwan in 2017, specializing in the importation, registration, marketing, and distribution of medical devices. With extensive experience in Taiwan’s medical device industry, AMM has developed strong expertise in regulatory requirements, product registration, import procedures, market access, and distribution channels. We work closely with international manufacturers and local healthcare professionals to introduce high-quality medical technologies that meet the needs of the Taiwan market.
AMM is committed to providing medical devices that combine clinical value, quality, and sustainable pricing. Through reliable regulatory support, market development, and distribution capabilities, we aim to expand treatment options for healthcare providers and patients in Taiwan and build long-term partnerships with our global partners.
Our Team
Growing Together, Not Alone
One important lesson from our history is that company growth never comes from one person alone.
Today's AMM Corp. is the result of a team that shares the same belief: that patients deserve better access to high-quality medical technology, and that hospitals and clinicians deserve a professional, trustworthy local partner.
Our colleagues have stood together through both difficult periods and successful ones, contributing their expertise in regulatory affairs, market development, clinical support, and daily operations. This collective effort is the foundation of our current scale and reputation.
For international manufacturers, our founding story explains how we look at partnerships:
- We understand the long road from product registration to real clinical adoption.
- We respect the importance of patient outcomes and hospital economics.
- And we believe in building transparent, long-term relationships rather than short-term distribution deals.
Journey & Milestones
Company Milestones
- 2017
AMM Corp. was established
- 2020
Started sales upon securing the exclusive distributorship of EMOSIST.
- 2023
GDP (Good Distribution Practice) approval
- 2024
Started sales upon securing the exclusive distributorship of AXIOSTAT.
- 2026
Started sales upon securing the exclusive distributorship of TIOLENE and OOZFIX.
Core Value and Vision
The Principles We Share
As a trusted Taiwan partner for foreign medical device companies, we focus on ethical execution, strong market insight, and long-term relationships with key customers. Together with our partners, we create market value and synergies through close collaboration, open communication, transparency, and mutual respect.
Our goal is to introduce products that enhance quality of care and meet unmet clinical and public health needs in Taiwan, with a particular focus on self-pay items. Inside the company, we uphold and reward high performance and the highest standards of ethical business conduct.
Organization
Our Orgainzation
Sales Department
Medical Device Department
Purchasing Department
Outsourced Warehouse & Cold-Chain Logistics
GDPCertified
License
Taiwan Good Distribution Practice
Taiwan's Good Distribution Practice (GDP) for medical devices is a TFDA regulatory framework to ensure that devices remain safe, effective, and of consistent quality throughout importation, storage, transportation and distribution. Importers and distributors of designated high-risk devices must establish a documented GDP quality system, pass TFDA inspection, and obtain a distribution license before engaging in wholesale, import, or export activities.
Our company has obtained Taiwan GDP certification (License No.: GDP0253), demonstrating full compliance with TFDA Good Distribution Practice requirements for medical devices.
